SIO GENE THERAPIES INC's ticker is and the CUSIP is 829399954. A total of 1 filers reported holding SIO GENE THERAPIES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $6,000 | -33.3% | 9,100 | +24.7% | 0.00% | – |
| Q4 2021 | $9,000 | +12.5% | 7,300 | +102.8% | 0.00% | – |
| Q3 2021 | $8,000 | -87.5% | 3,600 | -84.5% | 0.00% | – |
| Q2 2021 | $64,000 | -8.6% | 23,300 | -13.4% | 0.00% | – |
| Q1 2021 | $70,000 | +70.7% | 26,900 | +84.2% | 0.00% | – |
| Q4 2020 | $41,000 | – | 14,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |